First, we were unable to measure the progression of psoriasis vulgaris of blood-heat syndrome using serum markers in pretherapeutic patients, and only three/four eligible observation studies that reported serum IL-23/IL-6 levels were reviewed. Here, IL37 is linked to psoriasis vulgaris.